Which surgical approach offers better outcomes for prostate cancer: robotic-assisted or traditional open surgery? Radical prostatectomy, the surgical removal of the prostate gland, remains one of the treatment options for localised prostate cancer. The procedure can be performed through two distinct approaches: robotic-assisted laparoscopic surgery or traditional open surgery. Both methods aim to achieve the same oncological goal: complete removal of cancerous tissue while preserving urinary continence and erectile function. The choice between approaches depends on multiple factors. These include:
- Tumour characteristics
- Patient anatomy
- Surgeon experience
- Individual treatment priorities
The clinical evidence presents a nuanced picture. In this picture, a surgeon’s expertise frequently matters more than the specific approach chosen.
How Each Surgical Approach Works
Open Radical Prostatectomy
Open surgery involves a single incision, typically 8-10 centimetres. Urologists make this incision either in the lower abdomen (retropubic approach) or between the scrotum and anus (perineal approach). Healthcare providers more commonly use the retropubic approach. It allows simultaneous removal of pelvic lymph nodes for staging purposes (to determine if cancer has spread).
The surgeon works directly within the surgical field, with their hands inside the body cavity. This provides tactile feedback, the ability to feel tissue texture and tension. Some urologists consider this valuable for identifying nerve bundles and assessing tissue planes. The procedure typically requires 2-4 hours of operative time.
Robotic-Assisted Radical Prostatectomy
Robotic surgery uses 5-6 small incisions (8-12 millimetres each). Urologists insert a camera and robotic instruments through these incisions. The surgeon operates from a console several metres away. The console controls instruments that translate hand movements into precise micro-movements inside the patient’s body.
The robotic system provides three-dimensional high-definition magnification (substantial magnification), tremor filtration, and instruments with a greater range of motion than the human wrist. The pneumoperitoneum (inflating the abdomen with gas to create working space) reduces bleeding. It does this by compressing small blood vessels.
Surgical and Perioperative Outcomes
Blood Loss and Transfusion
Robotic prostatectomy demonstrates reduced blood loss during surgery compared to open surgery. The pneumoperitoneum creates a tamponade effect, compressing the bleeding site and helping stop bleeding. Magnified visualisation allows precise vessel control. Most robotic procedures involve blood loss of less than 200 millilitres. Open surgery typically results in 500-1000 millilitres.
Transfusion requirements reflect this difference. Blood transfusion is uncommon in robotic surgery. Open procedures carry a higher likelihood of requiring transfusion, particularly in cases with larger prostates or previous pelvic surgery.
Hospital Stay and Recovery Timeline
Robotic surgery typically requires 1-2 nights in the hospital. Many centres now offer same-day discharge protocols for selected patients. Open surgery generally requires 2-4 nights of hospitalisation.
The smaller incisions in robotic surgery result in less postoperative pain and reduced pain medication requirements. Most robotic patients transition from intravenous to oral pain medication within 24 hours. They return to light activities within 1-2 weeks. Open surgery patients typically require longer pain management. They need 4-6 weeks before resuming similar activity levels.
Catheter duration is similar between approaches, usually 7-14 days. This relates to the internal urethral anastomosis (the reconnection of the urethra after the prostate is removed) rather than external incisions.
Complication Rates
Overall complication rates between the two approaches are comparable when performed by urologists. The types of complications differ slightly:
- Robotic surgery carries small risks of port-site hernia, a hernia developing at one of the small incision sites, subcutaneous emphysema (air trapped under the skin), and complications related to steep head-down positioning required during the procedure
- Open surgery has higher rates of wound-related complications, including infection and hernia at the incision site
Serious complications occur rarely with both approaches. These include:
- Ureteral injury, or damage to the tubes connecting the kidneys to the bladder
- Rectal injury
- Deep vein thrombosis or blood clots in leg veins
They depend more on case complexity and surgeon experience than on the chosen technique.
Oncological Outcomes: Cancer Control
The primary purpose of radical prostatectomy is cancer cure. Healthcare professionals measure oncological outcomes through favourable surgical margin rates (cancer cells at the edge of removed tissue, which may indicate incomplete removal) and biochemical recurrence (rising PSA levels after surgery, suggesting cancer may have returned).
Positive Surgical Margins
Current evidence shows equivalent favourable margin rates between robotic and open approaches when controlled for tumour stage and grade. Margins depend on cancer extent, prostate anatomy, and surgical decision-making about nerve preservation rather than the technical approach.
For organ-confined disease (cancer that hasn’t spread beyond the prostate), favourable margin rates are low regardless of approach. For cancers extending beyond the prostate capsule, rates increase. The decision to perform a wider excision rather than a nerve-sparing approach involves a trade-off between cancer control and functional preservation. This trade-off exists independent of surgical technique.
Long-term Cancer Control
Studies with 10-year follow-up demonstrate equivalent biochemical recurrence-free survival between approaches. The cancer’s biological characteristics predict recurrence more reliably than surgical technique. These characteristics include:
- Gleason grade, a scoring system that describes how aggressive the cancer cells look
- PSA level, a protein produced by the prostate that can indicate cancer activity
- Tumour volume
Neither approach offers different cancer cure rates. The choice between them should not be made primarily on oncological grounds.
Functional Outcomes: Continence and Potency
The two significant quality-of-life concerns following prostatectomy are urinary incontinence (inability to control urination) and erectile dysfunction (difficulty achieving or maintaining erections). Both result from the unavoidable proximity of the prostate to the urinary sphincter (the muscle that controls urine flow) and neurovascular bundles, where nerve and blood vessel bundles that control erection.
Urinary Continence Recovery
Healthcare professionals typically define continence as using no pads or one security pad daily. Recovery follows a predictable pattern with both approaches:
- Immediately after catheter removal, Most men experience some leakage
- 3 months: Many men achieve social continence (minimal leakage with activity)
- 6-12 months: Most men reach final continence status
Studies comparing robotic and open approaches show conflicting results. Some demonstrate faster early continence recovery with robotic surgery. Others show equivalent outcomes. By 12 months, continence rates are similar between approaches. Your doctor will monitor your recovery progress. They can recommend pelvic floor exercises or other interventions to help support continence recovery.
Pre-surgical factors predicting continence outcomes include:
- Younger age
- Lower body mass index
- Absence of lower urinary tract symptoms, such as a weak stream or frequent urinatio,n before surgery
Surgical factors include preservation of urethral length and bladder neck.
Erectile Function Recovery
Erectile function recovery depends on nerve preservation, patient age, and pre-operative function. Men with strong erections before surgery, under age 60, who receive bilateral nerve-sparing surgery, where nerves on both sides are preserved, have higher recovery rates.
The magnification available in robotic surgery, in theory, enables nerve identification. However, comparative studies have not shown differences in erectile function outcomes between the two approaches. Your doctor can provide personalised advice. This will be based on your age, pre-surgery function, and the extent of nerve preservation possible given your cancer characteristics.
Erectile recovery is gradual. It often takes 18-24 months to reach final status. Most men require phosphodiesterase inhibitors (medications like sildenafil that help improve blood flow for erections) during recovery, regardless of surgical approach.
💡 Did You Know?
The neurovascular bundles responsible for erection run along the posterolateral surface of the prostate. They sit within millimetres of the prostatic capsule. Even with meticulous nerve-sparing technique, temporary dysfunction occurs. This happens due to nerve stretching and inflammation during dissection. This explains why recovery takes months rather than weeks.
The Role of Surgeon Experience
A consistent finding across surgical literature is that surgeon volume and experience correlate strongly with outcomes. High-volume urologists, those who perform many prostatectomy procedures, achieve outcomes regardless of whether they use robotic or open techniques.
Experience manifests in multiple ways:
- Patient selection: Matching appropriate cases to appropriate approaches
- Intraoperative decision-making: Knowing when to preserve versus remove tissue
- Complication management: Recognising and addressing problems promptly
- Case efficiency: Reduced operative time decreases anaesthesia exposure
When choosing a surgeon, case volume and outcomes data matter.
Cost and Accessibility Considerations
Direct Costs
Robotic surgery involves higher direct costs. These stem from equipment acquisition (the surgical system costs several million pounds), annual maintenance, and single-use instruments required for each case. Shorter hospital stays and reduced blood product usage partially offset these costs.
In Singapore, the out-of-pocket difference between approaches varies by institution and subsidy eligibility. Some centres absorb the additional robotic costs. Others pass them to patients.
Surgeon Availability
Robotic surgery requires specialised training and a high volume of cases to maintain proficiency. Not all urologists perform robotic surgery. Not all hospitals have robotic systems. Healthcare providers can perform open surgery at any hospital with appropriate facilities.
For patients in regions without robotic access, urologists can still achieve outcomes through open surgery.
Making Your Decision
Several factors should guide the choice between approaches:
Favouring Robotic Surgery
- Body habitus makes open surgery technically challenging, such as obesity, and a deep and narrow pelvis
- Preference for smaller incisions and faster return to physical activity
- Availability of a robotic surgeon
- No contraindications to steep head-down positioning
Favouring Open Surgery
- Huge prostate where robotic advantages diminish
- Prior extensive abdominal surgery with adhesions (scar tissue)
- Surgeon’s primary expertise is open technique
- Medical conditions precluding prolonged pneumoperitoneum
Either Approach Reasonable
Many cases of localised prostate cancer fall into this category. Surgeon experience and patient preference appropriately guide the decision.
When to Seek Professional Help
- Elevated PSA level on a screening blood test
- Abnormal findings on digital rectal examination
- Urinary symptoms such as difficulty starting urination, a weak stream, or frequent nighttime urination
- Family history of prostate cancer, particularly in first-degree relatives
- Previous prostate biopsy showing atypical cells requiring surveillance
Commonly Asked Questions
Does robotic surgery mean the robot operates?
No. The surgeon controls every movement from a console. The robotic system translates the surgeon’s hand movements into instrument movements inside the patient. It filters out tremor and scales motions. There is no autonomous function. The robot cannot make decisions or perform actions without direct surgeon input.
Will I definitely need to choose between cancer control and preserving function?
Not always. For many organ-confined cancers, appropriate nerve-sparing surgery can achieve both goals. Higher-risk cancers may require wider resection for oncological safety. Your surgeon can offer personalised advice based on MRI findings, biopsy results, and PSA level. They can advise whether nerve preservation is appropriate for your specific case.
How long will it be before I can return to normal activities?
Light activities (walking, desk work) are typically possible within 1-2 weeks with robotic surgery. Open surgery typically allows these activities after 3-4 weeks. Driving resumes once you stop taking narcotic pain medication, usually 1-2 weeks. Lifting restrictions (nothing over 5 kilograms) apply for 4-6 weeks. Sexual activity can resume once comfortable, typically 4-6 weeks. Erectile recovery takes longer, though.
What if cancer is found at the surgical margins?
Positive margins increase recurrence risk. They don’t mandate immediate additional treatment, though. Many men with positive margins remain cancer-free long-term. Management options include close PSA monitoring with intervention if recurrence develops, or adjuvant radiation therapy (additional radiation treatment after surgery). The decision incorporates margin extent, Gleason grade, and patient factors. Your doctor can work with you to determine an appropriate monitoring or treatment plan tailored to your individual situation.
Can the surgery be converted from robotic to open if needed?
Yes. Conversion occurs in a small percentage of robotic cases. This typically happens due to adhesions, bleeding, or equipment issues. Urologists recognise when conversion is appropriate. They proceed safely. You should discuss this possibility during consent. It should not be a primary concern when choosing an approach, though.
Next Steps
Both approaches achieve equivalent cancer control with similar long-term functional outcomes when performed by urologists. Robotic surgery offers reduced blood loss and faster early recovery. Your choice should incorporate tumour characteristics, surgeon expertise with each technique, and personal recovery priorities.
If you’ve been diagnosed with localised prostate cancer and are experiencing elevated PSA levels, abnormal digital rectal exam findings, or urinary symptoms such as a weak stream or frequent urination, consult a urologist to evaluate which surgical approach suits your specific case.
